Relationship between serum H-FABP, GDF-15, sICAM-1 and myocardial injury after percutaneous coronary intervention

XU Yi; WANG Jun-sheng; KAO Guo-ying; LI Jun

doi:10.11659/jjssx.12E022124

您当前的位置：

首页 >

文章列表页 >

Relationship between serum H-FABP, GDF-15, sICAM-1 and myocardial injury after percutaneous coronary intervention

Clinical Research | 更新时间：2023-10-23

- Relationship between serum H-FABP, GDF-15, sICAM-1 and myocardial injury after percutaneous coronary intervention
- JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY Vol. 32, Issue 10, Pages: 898-901(2023)
- 作者机构：
  
  重庆市急救医疗中心/重庆市第四人民医院心血管内科，重庆 400014
- 作者简介：
- 基金信息：
- DOI：10.11659/jjssx.12E022124
  CLC： R446.1
- Published：25 October 2023，
  
  Received：23 December 2022，
扫描看全文
徐艺,王均生,考国营等.血清H-FABP、GDF-15、sICAM-1与PCI后心肌损伤的关系分析[J].局解手术学杂志,2023,32(10):898-901.

XU Yi,WANG Jun-sheng,KAO Guo-ying,et al.Relationship between serum H-FABP, GDF-15, sICAM-1 and myocardial injury after percutaneous coronary intervention[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(10):898-901.
徐艺,王均生,考国营等.血清H-FABP、GDF-15、sICAM-1与PCI后心肌损伤的关系分析[J].局解手术学杂志,2023,32(10):898-901. DOI： 10.11659/jjssx.12E022124.

XU Yi,WANG Jun-sheng,KAO Guo-ying,et al.Relationship between serum H-FABP, GDF-15, sICAM-1 and myocardial injury after percutaneous coronary intervention[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(10):898-901. DOI： 10.11659/jjssx.12E022124.

摘要

目的

分析冠心病相关血清指标心型脂肪酸结合蛋白(H-FABP)、生长分化因子15(GDF-15)、可溶性细胞间黏附分子-1（sICAM-1）与经皮冠状动脉介入术(PCI)后心肌损伤的关系。

方法

回顾性选取2020年3月至2022年3月在本院接受PCI治疗的200例冠心病患者为研究对象，根据术后3个月是否出现心肌损伤，将其分为心肌损伤组（

=42）和心肌未损伤组（

=158）。比较2组各项临床资料及血清H-FABP、GDF-15、sICAM-1等实验室指标水平，并采用受试者工作特征（

ROC

）曲线分析以上指标与冠心病患者PCI后心肌损伤的关系。

结果

心肌损伤组患者从发病到治疗时间明显长于心肌未损伤组，血清H-FABP、GDF-15、sICAM-1水平均高于心肌未损伤组（

0.05）。建立相关性模型，结果显示，PCI后心肌受损与从发病到治疗时间相关性较弱（

=0.168，

0.05），与血清H-FABP、GDF-15、sICAM-1均存在中等程度相关（

=0.424、0.403、0.442，

0.05）。

ROC

曲线模型显示，血清H-FABP、GDF-15、sICAM-1均对PCI后心肌损伤具有一般诊断效能，三项联合检测具有较高准确性，其诊断

AUC

、约登指数、灵敏度、特异性分别为0.912、0.585、95.24%、63.29%。

结论

血清H-FABP、GDF-15、sICAM-1与冠心病患者PCI后心肌损伤的发生密切相关，三项血液指标联合检测对心肌损伤具有较高诊断和预测价值。

Abstract

Objective

To analyze the relationship between the serum indexes related to coronary heart disease of heart-type fatty acid-binding protein （H-FABP）， growth differentiation factor 15 （GDF-15）， soluble intercellular adhesion molecule-1 （sICAM-1） and myocardial injury after percutaneous coronary intervention （PCI）.

Methods

A total of 200 patients with coronary heart disease who received PCI in our hospital from March 2020 to March 2022 were retrospectively selected as the study subjects. According to whether myocardial injury occurred 3 months after operation，they were divided into the myocardial injury group （

=42） and the myocardial uninjuried group （

=158）. The clinical data and the serum levels of H-FABP， GDF-15 and sICAM-1 were compared between the two groups， and the relationship between the above indexes and myocardial injury after PCI was analyzed by

receiver operating characteristic

（

ROC

）curve.

Results

The time from onset to treatment in the myocardial injury group was significantly longer than that in the myocardial uninjuried group， and the serum levels of H-FABP， GDF-15 and sICAM-1 were higher than those in the myocardial uninjuried group （

0.05）. The correlation model was established and the results showed that the myocardial injury after PCI was weakly correlated with the time from onset to treatment （

=0.168，

0.05），and moderately correlated with serum H-FABP，GDF-15 and sICAM-1 （

=0.424， 0.403， 0.442，

0.05）.

ROC

curve model showed that the serum H-FABP，GDF-15 and sICAM-1 all had general diagnostic efficacy for myocardial injury after PCI，and the three combined tests had higher accuracy，with diagnostic

AUC

，Youden index，sensitivity and specificity of 0.912， 0.585， 95.24% and 63.29%，respectively.

Conclusion

Serum H-FABP，GDF-15 and sICAM-1 are closely related to the myocardial injury of patients with coronary heart disease after PCI.The combined detection of these three blood indexes has high diagnostic and predictive value for myocardial injury.

关键词

心型脂肪酸结合蛋白生长分化因子15可溶性细胞间黏附分子-1心肌损伤

Keywords

heart-type fatty acid-binding proteingrowth differentiation factor 15soluble intercellular adhesion molecule-1myocardial injury

references

Wang H， Gong H， Liu Y， et al. Relationship between lncRNA-Ang362 and prognosis of patients with coronary heart disease after percutaneous coronary intervention［J］. Biosci Rep， 2020， 40（7）：BSR20201524.doi：10.1042/BSR20201524http://dx.doi.org/10.1042/BSR20201524.

Shi Y， Zhang S， Xue Y， et al. IL-35 polymorphisms and cognitive decline did not show any association in patients with coronary heart disease over a 2-year period： a retrospective observational study （STROBE compliant）［J］. Medicine， 2020， 99（31）：e21390.doi：10.1097/MD.0000000000021390http://dx.doi.org/10.1097/MD.0000000000021390.

刘玉文，钱进，王能，等. 经远端桡动脉行冠状动脉介入治疗的可行性及安全性研究［J］. 微循环学杂志， 2020， 30（2）：39-43.doi：10.3969/j.issn.1005-1740.2020.02.009http://dx.doi.org/10.3969/j.issn.1005-1740.2020.02.009.

Hunt SA，Abraham WT，Chin MH，et al. ACC/AHA2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article ：A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines（Writing Committee to Updat［J］.J Am Coll Cardiol，2005，46（6）：1116-1143.doi：10.1016/j.jacc.2005.08.023http://dx.doi.org/10.1016/j.jacc.2005.08.023.

韩雅玲. 2016中国经皮冠状动脉介入治疗指南解读［J］. 临床军医杂志， 2016， 44（5）：441-443.doi：10.3760/cma.j.issn.0253-3758. 2009.01.003http://dx.doi.org/10.3760/cma.j.issn.0253-3758.2009.01.003.

Tsai HY， Wu YW， Tseng WK， et al. Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions［J］. J Formos Med Assoc， 2020， 120（1 Pt 3）：728-736.doi：10.1016/j.jfma.2020.08.007http://dx.doi.org/10.1016/j.jfma.2020.08.007.

Andersson J， Fall T， Delicano R， et al. GDF-15 is associated with sudden cardiac death due to incident myocardial infarction［J］. Resuscitation， 2020， 152：165-169.doi：10.1016/j.resuscitation. 2020. 05.001http://dx.doi.org/10.1016/j.resuscitation.2020.05.001.

辛艳峰，吴振华，郭莉清，等. 稳定型冠心病患者vWF，ET-1，sICAM-1水平对急性心肌梗死发病风险的联合预测价值［J］. 解放军医药杂志， 2022， 34（2）：74-78.doi：10.3969/j.issn.2095-140X.2022.02.017http://dx.doi.org/10.3969/j.issn.2095-140X.2022.02.017.

李安琪，刘江华. 糖尿病大血管病变的诊断及早期治疗进展［J］.江苏大学学报（医学版），2021，31（4）： 363-368.doi：10.13312/j.issn.1671-7783.y210024http://dx.doi.org/10.13312/j.issn.1671-7783.y210024.

Xie Q， Huang J， Zhu K， et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary heart disease and type 2 diabetes mellitus： cumulative meta-analysis［J］. Clin Cardiol， 2021， 44（7）：899-906.doi：10.1002/clc.23613http://dx.doi.org/10.1002/clc.23613.

Safyanova OE， Repin AN. Aggressive therapy to prevent contrast-induced kidney damage during percutaneous coronary interventions［J］. Eur Heart J， 2020， 41（2）.doi：10.1093/ehjci/ehaa946.1479http://dx.doi.org/10.1093/ehjci/ehaa946.1479.

董静. 三维超声心动图评价冠心病心力衰竭病人左心功能及其与血清NT-proBNP，H-FABP水平的相关性分析［J］. 中西医结合心脑血管病杂志， 2020， 18（22）：3837-3840.doi：10.12102/j.issn.1672-1349.2020.22.028http://dx.doi.org/10.12102/j.issn.1672-1349.2020.22.028.

高洁，易蔚，吕珊珊，等. 血清心型脂肪酸结合蛋白，游离脂肪酸对老年冠心病患者经皮冠状动脉介入术后心肌损伤的诊断价值［J］. 实用临床医药杂志， 2021， 25（21）：28-32.doi：10.7619/jcmp.20212194http://dx.doi.org/10.7619/jcmp.20212194.

Paepe BD， Verhamme F， Bleecker J. The myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis［J］. Cytokine， 2020， 127：154966.doi：10.1016/j.cyto.2019.154966http://dx.doi.org/10.1016/j.cyto.2019.154966.

代江娜，赵晓静，刘霄岩，等. 老年冠心病患者GDF-15，hs-CRP的表达及与心脏外膜脂肪厚度的相关性分析［J］. 标记免疫分析与临床， 2022， 29（1）：67-70.doi：10.11748/bjmy.issn.1006-1703.2022.01.015http://dx.doi.org/10.11748/bjmy.issn.1006-1703.2022.01.015.

Shrestha P， Davis DA， Jaeger HK， et al. Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2［J］. PLoS Pathog， 2021， 17（1）：e1009091.doi：10.1371/journal.ppat.1009091http://dx.doi.org/10.1371/journal.ppat.1009091.

Mason RP， Dawoud H， Sherratt S， et al. 959： eicosapentaenoic acid inhibits ICAM-1 expression in pulmonary endothelial cells with inflammation［J］. Crit Care Med， 2021， 49（1）：477.doi：10.1097/01.ccm.0000729724.73455.27http://dx.doi.org/10.1097/01.ccm.0000729724.73455.27.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Diagnostic significance of CK-MB, MYO and hs-cTnT for myocardial injury in patients with sepsis

A study on cardiovascular injury of anesthesia rat induced by chronic intermittent hypoxia

Related Author

WU Yong-hua

YAO Li-ying

SU Wei

LIU Du

JIANG Rong

YANG Mengchang

DENG Jia

LIANG Tao

Related Institution

Department of Medical Laboratory，Mianyang Central Hospital Affiliated to Medical College of University of Electronic Science and Technology of China

Department of Health Services， Mianyang Central Hospital Affiliated to Medical College of University of Electronic Science and Technology of China

Department of Anesthesiology,People’s Hospital of Sichuan Province,Sichuan Academy of Medical Sciences

⁰